Distribution and elimination of levamisole in eggs and tissues after oral administration to laying hens, determined by LC-MS/MS.

Levamisole was administered to laying hens, and concentrations in eggs and tissues (thigh muscle, breast muscle, liver and kidney) were determined by a newly developed liquid chromatography tandem mass spectrometry method, which allowed trace level quantification of levamisole. The adopted analytical method showed good sensitivity, repeatability and percentage of recovery from spiked matrices. Maximum concentrations of levamisole were found on the first day after the administration (531.1 µg/kg in liver, 164.3 µg/kg in egg yolk, 130.7 µg/kg in kidney, 78.0 µg/kg in breast muscle, 70.7 µg/kg in thigh muscle and 64.0 µg/kg in egg white), after which there is a decline. The compound was rapidly eliminated from eggs, with a half-life of 1.3 days. Elimination appeared to be slower in thigh muscle (3.5 days), breast muscle (3.4 days) and liver (3.3 days). According to this experiment, the levamisole withdrawal periods calculated for eggs, liver, kidney, breast muscle and thigh muscle in laying hens were 14.1, 6.1, >4.0, 14.5 and 13.0 days, respectively. The longest time for levamisole residues to be completely released from tissues was seen in liver samples (37.4 days), followed by thigh muscle, breast muscle and kidney. Elimination from eggs was fastest (16.4 days for levamisole residues to drop below the method quantification limit).

Validation of a multi-residue enzyme-linked immunosorbent assay for qualitative screening of corticosteroids in liver, urine and milk.

A rapid and sensitive enzyme-linked immunosorbent assay (ELISA) was applied for the qualitative screening analysis of dexamethasone, betamethasone, flumethasone, and prednisolone in milk and urine, and dexamethasone, flumethasone and prednisolone in liver samples at levels corresponding to the European Union maximum residue limit (MRL), or at required performance levels (RPLs) for substances for which there is no established MRL. Method validation was performed according to Commission Decision 2002/657/EC criteria established for qualitative screening methods. In this regard, the following parameters were determined: detection capability (CCß), specificity, limit of detection (LOD), limit of quantitation (LOQ), recovery, within-laboratory reproducibility, linearity and ruggedness. LODs were 0.2, 1.2 and 0.6 µg kg(-1) in milk, urine and liver samples, and LOQ values were 0.3, 1.2 and 1.4 µg kg(-1) in milk, urine and liver, respectively. Recoveries from spiked samples ranged from 68% to 131% for dexamethasone, from 57% to 120% for flumethasone, from 60% to 155% for betamethasone, and from 23% to 32% for prednisolone, with a coefficient of variation (CV) between 1.6% and 21.2%. The CCß value was below the MRL/RPL for all examined matrices. Moderate variations of some critical factors in the sample pre-treatment for liver and milk samples were deliberately introduced for ruggedness evaluation and did not result in any negative effects on corticosteroid detection. The proposed method is suitable for qualitative screening analysis of corticosteroids in the above-mentioned food in conformity with the current European Union performance requirements.

Validation of an enzyme-linked immunosorbent assay for qualitative screening of neomycin in muscle, liver, kidney, eggs and milk.

A rapid and sensitive enzyme-linked immunosorbent assay (ELISA) was used for the qualitative screening analysis of neomycin in food of animal origin (muscle, liver, kidney, eggs and milk) at levels corresponding to the European Union maximum residue limit (MRL) set for this substance. The method validation was performed according to the criteria of Commission Decision 2002/657/EC established for qualitative screening methods. In this regard, the following parameters were determined: detection capability (CCß), specificity, detection limit (LOD), quantification limit (LOQ), recovery, precision, linearity and ruggedness. LODs ranged from 5.7 microg kg(-1) in kidney to 29.3 microg kg(-1) in milk; LOQs ranged from 11.4 microg kg(-1) in kidney to 59.7 microkg(-1) in eggs. The recoveries from spiked samples at the MRL, half the MRL and double the MRL levels ranged from 65.8% to 122.8%, with a coefficient of variation (CV) between 5.9% and 28.6%. The CCß value was less than the MRL for all examined matrices. Moderate variations of some critical factors in the sample pretreatment for muscle, milk and eggs were deliberately introduced for ruggedness evaluation and had a slight but not statistically significant effect on method performance. The proposed method is suitable for qualitative screening analysis of neomycin in the above-mentioned food in conformity with current European Union performance requirements.

Cortisol and immune measures in boars exposed to three-day administration of exogenous adrenocorticotropic hormone.

The aim of the study was to evaluate the effect of adrenal stimulation by adrenocorticotropic hormone (ACTH) on blood cortisol concentration and on circulating total and differential leukocyte counts during and in the 16 days after ACTH administration. Swedish Landrace boars aged approximately 6-7 months were used. ACTH-treated animals (n = 7) were given ACTH intravenously at 10 microg/kg body mass for 3 days. A control group of animals (n = 7) received 1 ml of sterile 0.9% saline intramuscularly. ACTH induced a highly significant increase (p>0.0001) in serum cortisol in treated boars. On the day after the last ACTH dose, the cortisol concentration was significantly higher, but the level of significance was lower than during ACTH administration (p>0.05). During ACTH treatment, a significant increase was recorded in total leukocyte count and neutrophil percentage (p>0.05 to p>0.0001), along with the increase in blood cortisol concentration, whereas percentage lymphocyte count showed a significant decrease. Lymphopenia disappeared upon cessation of treatment, but neutropenia developed in the week after treatment. On all three days of ACTH challenge, the neutrophil-to-lymphocyte ratio was significantly increased. An increase in eosinophil percentage was recorded on treatment days 1 and 2, whereas ACTH treatment had no effect on basophil percentage. In conclusion, three-day administration of ACTH to young boars during restraint caused effects similar to acute stress situations, as suggested by disappearance of the effects on immune function after the last drug dosage.

Effect of ACTH administration on biochemical and immune measures in boars.

The effects of stress induced by adrenocorticotropic hormone (ACTH) on biochemical and immune changes in Swedish Landrace boars aged approximately 6-7 months were observed during ACTH administration and for 16 days after the cessation of treatment. Adrenocorticotropic hormone treated animals (n = 7) were given intravenously 10 microg/kg body mass of ACTH for 3 days. Control group of animals (n = 7) received intramuscularly 1 ml of sterile 0.9% saline. Total protein and globulin levels were significantly elevated during the induced stress period and for the next 16 days (P < 0.01 to P < 0.0001, respectively). Also, serum immunoglobulin IgG concentration was significantly elevated during and after ACTH injection (P < 0.001 to P < 0.0001). Adrenocorticotropic hormone treatment had no effect on serum albumin, IgA and IgM concentrations. Glucose concentration was significantly decreased on the second day of ACTH administration (P < 0.001) and on day 9 after treatment (P < 0.001). Calcium level was significantly decreased only for 24 h after the last ACTH dosage (P < 0.01). Also, serum phosphorus level was significantly decreased on the first (P < 0.05) and third (P < 0.001) days of ACTH challenge but remained unaffected after the cessation of ACTH treatment. It is concluded that the administration of ACTH to boars results in immune humoral and biochemical changes during stress and the post-stress period.

Acute and subacute metabolic and endocrine effects of clenbuterol in female pigs.

The aim of the study was to assess the relationship between acute and subacute metabolic and endocrine effects after intravenous administration of the beta2-adrenergic agonist clenbuterol in a growth-promoting dose to female pigs. Acute metabolic and endocrine effects were assessed by measuring the blood glucose, serum insulin and nonesterified fatty acid (NEFA) concentrations during 300 min after a single administration of clenbuterol. Significantly higher serum insulin and NEFA concentrations (19.90 +/- 2.50 microU/ml, p<0.01, and 0.69 +/- 0.04 mmol/L, p<0.001, respectively) were measured 30 min after the preprandial administration of clenbuterol in female pigs. Over the same period, the levels of blood glucose (4.42 +/- 0.30 mmol/L) showed no difference from those of control pigs. The postprandial serum NEFA concentration decreased moderately during 210 min after feeding. Postprandial blood glucose and insulin concentrations increased and reached maximal levels 120 min after clenbuterol administration (10.91 +/- 0.60 mmol/L and 85.22 +/- 7.24 microU/ml, respectively), and returned to basal levels at 300 min (4.20 +/- 0.21 mmol/L and 7.75 +/- 1.60 microU/ml, respectively) after the administration of clenbuterol. Subacute metabolic and endocrine effects were assessed by measuring the blood glucose, serum insulin and NEFA concentrations for 21 days after the repeated doses of clenbuterol. In addition, the influence of clenbuterol administration on the endocrine regulation of the onset of the next expected oestrus in female pigs was assessed by measuring their serum 17beta-oestradiol and progesterone concentrations. Blood glucose, serum insulin and NEFA concentrations after the last administration of clenbuterol did not differ significantly from those in control animals. The onset of the next expected oestrus occurred regularly without any significant difference in serum 17beta-oestradiol or progesterone concentrations between the treated (9.83 +/- 2.60 pg/ml and 0.15 +/- 0.03 ng/ml) and control pigs (8.52 +/- 2.70 pg/ml and 0.25 +/- 0.06 ng/ml). The study results suggest the duration of intravenous administration of clenbuterol in a growth-promoting dose necessary to influence the metabolic and endocrine activities in female pigs.

Reproductive disturbance caused by an S-triazine herbicide in pigs.

The aim of the study was to assess the effect of subacute treatment with a low dose of atrazine (1,3,5-triazine-2,4-diamine, 6-chloro-N-ethyl-N'-(1-methyl-ethyl), an s-triazine herbicide, on endocrine oestrus regulation in gilts. A group of nine gilts (F1 generation of Swedish Landrace x Large Yorkshire) were treated with 1 mg atrazine/kg body mass daily, mixed to the feed for 19 days before the onset of expected oestrus. Blood samples were obtained by cranial vena cava puncture three times daily at 3-h intervals on five post-treatment days, i.e. before and during oestrus. The serum concentration of oestradiol-17 beta (E2) was determined by the fluoroimmunochemical method. On Day -2 before the onset of expected oestrus, a significantly lower (P < 0.001) E2 concentration was measured in the serum of treated gilts (31.25 +/- 1.95 and 39.32 +/- 1.38 pg/mL) than in the control pigs (51.43 +/- 1.29 and 68.59 +/- 2.99 pg/mL). In contrast, the E2 concentration measured in the serum of treated animals was significantly higher (P < 0.001) on the day of the expected onset of oestrus and on the subsequent two days (35.43 +/- 1.85, 53.92 +/- 1.98 and 60.32 +/- 2.35 pg/mL, respectively) than in the control animals (13.52 +/- 1.79, 21.53 +/- 1.35 and 20.05 +/- 1.46 pg/mL, respectively). Insufficient serum E2 concentration of the treated gilts resulted in a failure of expected oestrus, as indicated also by the state of dioestrus demonstrated by histopathological examination of the uterus.

Seasonal atrazine contamination of drinking water in pig-breeding farm surroundings in agricultural and industrial areas of Croatia.

Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine) a s-triazine herbicide, has been widely used in Croatian agriculture. Due to atrazine extensive use and its biodegradation in nature within at least one year (Klassen and Kodoum 1979), atrazine residues are found in ground, surface, drain and drinking water (Vidacek et al. 1994; Gojmerac et al. 1994). Groundwater downgradient from atrazine treated fields may show seasonal concentration peaks which could exceed the safe level (Wehtje et al. 1983). Therefore, the use of atrazine includes permanent control of its residues in water, particularly in relation to its use as a herbicidal chemical and groundwater contamination (Graham 1991). Furthermore, the presence of atrazine in the environment and its possible ingestion via the water, food and feed chain, may present a risk for the animal and human health. The analysis of atrazine residues in soil can be performed by either colorimetry or high performance liquid chromatography (HPLC) (Vickrey et al. 1980), and in water, soil and food by immunoassay in comparison with HPLC or gas chromatography/mass spectrometry (GS-MS) (Bushway et al. 1988; Bushway et al. 1989; Bushway et al. 1992; Thurman et al. 1990). We describe the use of enzyme-linked immunosorbent assay (ELISA) for one-year seasonal monitoring of atrazine residues in drinking water from two differently situated pig-breeding farms (agricultural and industrial areas) in Croatia. Results obtained by ELISA were compared to those produced by HPLC.